Development asset linked to Corbus Pharmaceuticals in public FDA and regional records.
pharma · Dermatomyositis · Diffuse Cutaneous Systemic Sclerosis · CRBP
Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
500 River Ridge Dr, Norwood, Massachusetts 02062, US HQ
2014 Founded
57 Employees
Public company Type
CRBP · NYSE Ticker
Company details
- Status
- Public
- HQ
- 500 River Ridge Dr, Norwood, Massachusetts 02062, US
- Founded
- 2014
- Employees
- 57
- Programs
- 11
- Drugs
- 3
- Patents
- 6
Corbus Pharmaceuticals pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Corbus Pharmaceuticals drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Corbus Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Corbus Pharmaceuticals in public FDA and regional records.